Circumvention of resistance by doxorubicin, but not by idarubicin, in a human leukemia cell line containing an intercalator-resistant form of topoisomerase II: evidence for a non-topoisomerase II-mediated mechanism of doxorubicin cytotoxicity
- 26 January 1993
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 45 (2), 516-520
- https://doi.org/10.1016/0006-2952(93)90091-a
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Two independent amsacrine-resistant human myeloid leukemia cell lines share an identical point mutation in the 170 kDa form of human topoisomerase IIJournal of Molecular Biology, 1992
- DNA Damage and Cytotoxicity Induced by Metabolites of Anthracycline Antibiotics, Doxorubicin and IdarubicinCancer Communications, 1991
- Cross-resistance of an amsacrine-resistant human leukemia line to topoisomerase II reactive DNA intercalating agents. Evidence for two topoisomerase II directed drug actionsBiochemistry, 1991
- Characterization of an Amsacrine-resistant Line of Human Leukemia CellsJournal of Biological Chemistry, 1989
- Formation, resealing and persistence of DNA breaks produced by 4-demethoxydaunorubicin in P388 leukemia cellsChemico-Biological Interactions, 1989
- Oral 4-demethoxydaunorubicin (idarubicin) in bronchogenic lung cancer; Phase II trialInvestigational New Drugs, 1986
- Adriamycin-Induced DNA Damage Mediated by Mammalian DNA Topoisomerase IIScience, 1984
- Protein-associated deoxyribonucleic acid strand breaks in L1210 cells treated with the deoxyribonucleic acid intercalating agents 4'-(9-acridinylamino)methanesulfon-m-anisidide and adriamycinBiochemistry, 1981
- Qualitative and quantitative aspects of intercalator-induced DNA strand breaksBiochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis, 1979
- The incorporation of 3H-cytosine arabinoside and its effect on murine leukemic cells (L5178Y)Biochemical Pharmacology, 1968